<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37036020</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>17</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>19</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1477-0962</ISSN><JournalIssue CitedMedium="Internet"><Volume>32</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>May</Month></PubDate></JournalIssue><Title>Lupus</Title><ISOAbbreviation>Lupus</ISOAbbreviation></Journal><ArticleTitle>In-person versus virtual administration of the American College of Rheumatology gold standard cognitive battery in systemic lupus erythematosus: Are they interchangeable?</ArticleTitle><Pagination><StartPage>737</StartPage><EndPage>745</EndPage><MedlinePgn>737-745</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1177/09612033231168477</ELocationID><Abstract><AbstractText Label="OBJECTIVE" NlmCategory="OBJECTIVE">During the COVID-19 pandemic, many research studies were adapted, including our longitudinal study examining cognitive impairment (CI) in systemic lupus erythematosus (SLE). Cognitive testing was switched from in-person to virtual. This analysis aimed to determine if the administration method (in-person vs. virtual) of the ACR-neuropsychological battery (ACR-NB) affected participant cognitive performance and classification.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">Data from our multi-visit, SLE CI study included demographic, clinical, and psychiatric characteristics, and the modified ACR-NB. Three analyses were undertaken for cognitive performance: (1) all visits, (2) non-CI group visits only and (3) intra-individual comparisons. A retrospective preferences questionnaire was given to participants who completed the ACR-NB both in-person and virtually.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">We analysed 328 SLE participants who had 801 visits (696 in-person and 105 virtual). Demographic, clinical, and psychiatric characteristics were comparable except for ethnicity, anxiety and disease-related damage. Across all three comparisons, six tests were consistently statistically significantly different. CI classification changed in 11/71 (15%) participants. 45% of participants preferred the virtual administration method and 33% preferred in-person.</AbstractText><AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">Of the 19 tests in the ACR-NB, we identified one or more problems with eight (42%) tests when moving from in-person to virtual administration. As the use of virtual cognitive testing will likely increase, these issues need to be addressed - potentially by validating a virtual version of the ACR-NB. Until then, caution must be taken when directly comparing virtual to in-person test results. If future studies use a mixed administration approach, this should be accounted for during analysis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Barraclough</LastName><ForeName>M L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation><Identifier Source="RINGGOLD">5292</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Diaz-Martinez</LastName><ForeName>J P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Knight</LastName><ForeName>A</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7979</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Neurosciences and Mental Health Program, SickKids Research Institute, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bingham</LastName><ForeName>K</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Centre for Mental Health, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Department of Psychiatry, University of Toronto, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Su</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7979</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kakvan</LastName><ForeName>M</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Grajales</LastName><ForeName>C Mu&#xf1;oz</ForeName><Initials>CM</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tartaglia</LastName><ForeName>M C</ForeName><Initials>MC</Initials><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network Memory Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ruttan</LastName><ForeName>L</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>University Health Network-Toronto Rehabilitation Institute, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7961</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wither</LastName><ForeName>J</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Choi</LastName><ForeName>M Y</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Cumming School of Medicine, University of Calgary, Calgary, AB, Canada.</Affiliation><Identifier Source="RINGGOLD">70401</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bonilla</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Anderson</LastName><ForeName>N</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Appenzeller</LastName><ForeName>S</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Orthopaedics, Rheumatology and Traumatology, University of Campinas, S&#xe3;o Paulo, Brazil.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parker</LastName><ForeName>B</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation><Identifier Source="RINGGOLD">5292</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Katz</LastName><ForeName>P</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-8146-2519</Identifier><AffiliationInfo><Affiliation>University of California, San Francisco, CA, USA.</Affiliation><Identifier Source="RINGGOLD">8785</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Beaton</LastName><ForeName>D</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Institute for Work and Health, University of Toronto, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7966</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Green</LastName><ForeName>R</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Krembil Research Institute, University Health Network Memory Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bruce</LastName><ForeName>I N</ForeName><Initials>IN</Initials><Identifier Source="ORCID">0000-0003-3047-500X</Identifier><AffiliationInfo><Affiliation>Centre for Epidemiology Versus Arthritis, Division of Musculoskeletal and Dermatological Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, The University of Manchester, Manchester, UK.</Affiliation><Identifier Source="RINGGOLD">5292</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>NIHR Manchester Biomedical Research Centre, Manchester Academic Health Science Centre, Manchester University NHS Foundation Trust, Manchester, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Touma</LastName><ForeName>Z</ForeName><Initials>Z</Initials><Identifier Source="ORCID">0000-0001-5177-2076</Identifier><AffiliationInfo><Affiliation>Schroeder Arthritis Institute, Krembil Research Institute, University Health Network, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7989</Identifier></AffiliationInfo><AffiliationInfo><Affiliation>Centre for Prognosis Studies in Rheumatic Diseases, Toronto Western Hospital, University of Toronto Lupus Clinic, Toronto, ON, Canada.</Affiliation><Identifier Source="RINGGOLD">7938</Identifier></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>04</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Lupus</MedlineTA><NlmUniqueID>9204265</NlmUniqueID><ISSNLinking>0961-2033</ISSNLinking></MedlineJournalInfo><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014481" MajorTopicYN="N" Type="Geographic">United States</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000523" MajorTopicYN="N">psychology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012219" MajorTopicYN="Y">Rheumatology</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008137" MajorTopicYN="N">Longitudinal Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058873" MajorTopicYN="N">Pandemics</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003071" MajorTopicYN="N">Cognition</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">cognitive impairment</Keyword><Keyword MajorTopicYN="N">neuropsychiatric lupus</Keyword><Keyword MajorTopicYN="N">systemic lupus erythematosus</Keyword></KeywordList><CoiStatement>MB reports financial support by Arthritis Society of Canada, Canadian Institutes
of Health Research, Physician&#x2019;s Services Incorporated, The Province of Ontario
Early Research Award, The Lupus Research Alliance, Lupus Canada, Lupus UK, and
has honoraria from UHN International conference on Arthritis; AK reports grants
from Lupus Research Alliance &amp; US Department of Defense; CIHR Long Covid
study grant; KB reports financial support from Labatt Family Network and
University of Toronto Dept of Psychiatry&#x2019;s Excellence Fund; CM receives
consulting fees from MitogenDx, Mallinckrodt Pharmaceuticals, AstraZeneca, GSK;
JW reports indirect support from Lupus 21st Century &#x2013; indirect support from
multiple drug companies, participation on Astra Zeneca Advisory Board, indirect
salary support from unrestricted funds given by Pfizer for a research chair in
the Division of Rheumatology; MYC reports consulting fees from MitogenDx,
Mallinckrodt Pharmaceuticals, AstraZeneca, GSK; BP reports consulting fees from
Fresenius Kabi and Vifor Pharma, honoraria from Astra Zeneca, UCB and Roche
Chugai, meeting attendance support from Abbvie and Eli Lilly; DB is executive
director &amp; chair of OMERACT; zettatesla is supported by grants from
Schroeder Arthritis Institute, Lupus Ontario, Arthritis Society of Canada,
Canadian Institutes of Health Research, Physicians&#x2019; Services Incorporated, The
Province of Ontario (Early Research Award), The Lupus Research Alliance and
reports a relationship with consulting fees from AstraZeneca AB, Merck KGaA,
GlaxoSmithKline Inc, and UCB Biopharma SRL, and Sarkana Pharma, Inc.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>17</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>4</Month><Day>11</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>4</Month><Day>10</Day><Hour>6</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>5</Month><Day>17</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37036020</ArticleId><ArticleId IdType="pmc">PMC10189815</ArticleId><ArticleId IdType="doi">10.1177/09612033231168477</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Waldroff K. As the US stays home, psychology moves online.
https://www.apa.org/monitor/2020/06/covid-psychology-online: American
Psychological Association; 2020Available
from: https://www.apa.org/monitor/2020/06/covid-psychology-online</Citation></Reference><Reference><Citation>Yuen K, Green R, Bingham K, et al.Metrics and definitions used in the assessment of cognitive impairment in systemic lupus erythematosus: a systematic review. Semi Arth Rheu 2021; 51(4): 819&#x2013;830.</Citation><ArticleIdList><ArticleId IdType="pubmed">34157577</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuen K, Beaton D, Bingham K, et al.Validation of the automated neuropsychological assessment metrics for assessing cognitive impairment in systemic lupus erythematosus. Lupus 2022; 31(1): 45&#x2013;54.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8793300</ArticleId><ArticleId IdType="pubmed">34957878</ArticleId></ArticleIdList></Reference><Reference><Citation>CANTAB(R) . [Cognitive assessment software].
2016https://www.cantab.com.CCArr</Citation></Reference><Reference><Citation>Backx R, Skirrow C, Dente P, et al.Comparing web-based and lab-based cognitive assessment using the Cambridge neuropsychological test automated battery: a within-subjects counterbalanced study. J Medi Inter Res 2020; 22(8): e16792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7435628</ArticleId><ArticleId IdType="pubmed">32749999</ArticleId></ArticleIdList></Reference><Reference><Citation>Nomenclature AAHCNL . The American college of rheumatology nomenclature and case definitions for neuropsychiatric lupus syndromes. Arth and rhe 1999; 42(4): 599&#x2013;608.</Citation><ArticleIdList><ArticleId IdType="pubmed">10211873</ArticleId></ArticleIdList></Reference><Reference><Citation>He JW, Diaz Martinez JP, Bingham K, et al.Insight into intraindividual variability across neuropsychological tests and its association with cognitive dysfunction in patients with lupus. Lupus Sci &amp; Med 2021; 8(1): e000511.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8493902</ArticleId><ArticleId IdType="pubmed">34610995</ArticleId></ArticleIdList></Reference><Reference><Citation>Aringer M, Costenbader K, Daikh D, et al.2019 European league against rheumatism/american college of rheumatology classification criteria for systemic lupus erythematosus. Annals of the Rheumatic Diseases 2019; 78(9): 1151&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pubmed">31383717</ArticleId></ArticleIdList></Reference><Reference><Citation>Shapiro AM, Benedict RH, Schretlen D, et al.Construct and concurrent validity of the Hopkins verbal learning test&#x2014;revised. The Clin Neuropsy 1999; 13(3): 348&#x2013;358.</Citation><ArticleIdList><ArticleId IdType="pubmed">10726605</ArticleId></ArticleIdList></Reference><Reference><Citation>Reitan RM, Wolfson D. The Halstead-Reitan neuropsychological test battery: theory and clinical interpretation. Tucson, AZ: Neuropsychology Press, 1985.</Citation></Reference><Reference><Citation>Tayer-Shifman OE, Green R, Beaton DE, et al.Validity evidence for the use of automated neuropsychologic assessment metrics as a screening tool for cognitive impairment in systemic lupus erythematosus. Arth Care Res 2020; 72(12): 1809&#x2013;1819.</Citation><ArticleIdList><ArticleId IdType="pubmed">31628718</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruchinskas RA. Limitations of the oral trail making test in a mixed sample of older individuals. The Clinical Neuropsychologist 2003; 17(2): 137&#x2013;142.</Citation><ArticleIdList><ArticleId IdType="pubmed">13680420</ArticleId></ArticleIdList></Reference><Reference><Citation>Rogers F, Bane E, Dwyer CP, et al.Remote administration of BICAMS measures and the trail-making test to assess cognitive impairment in multiple sclerosis. Neuropsy Rehab 2022; 17: 1&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">35297748</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowler R, Sudia S, Mergler D, et al.Comparison of digit symbol and symbol digit modalities tests for assessing neurotoxic exposure. Cli Neuropsychologist 1992; 6(1): 103&#x2013;104.</Citation></Reference><Reference><Citation>Jaeger J. Digit symbol substitution test. J Clin Psycho 2018; 38(5): 513&#x2013;519.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6291255</ArticleId><ArticleId IdType="pubmed">30124583</ArticleId></ArticleIdList></Reference><Reference><Citation>Moran TP. Anxiety and working memory capacity: a meta-analysis and narrative review. Psycholo Bulletin 2016; 142(8): 831&#x2013;864.</Citation><ArticleIdList><ArticleId IdType="pubmed">26963369</ArticleId></ArticleIdList></Reference><Reference><Citation>Stawski RS, Sliwinski MJ, Smyth JM. Stress-related cognitive interference predicts cognitive function in old age. Psycho and Aging 2006; 21(3): 535&#x2013;544.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2957652</ArticleId><ArticleId IdType="pubmed">16953715</ArticleId></ArticleIdList></Reference><Reference><Citation>COVID-19 Mental Disorders Collaborators . Global prevalence and burden of depressive and anxiety disorders in 204 countries and territories in 2020 due to the COVID-19 pandemic. Lancet 2021; 398(10312): 1700&#x2013;1712.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8500697</ArticleId><ArticleId IdType="pubmed">34634250</ArticleId></ArticleIdList></Reference><Reference><Citation>Honeyman MMD, Evans H, Davies A. Digital technology and health inequalities: a scoping review. Cardiff: Public Health Wales NHS Trust, 2020.</Citation></Reference><Reference><Citation>Beishon LC, Elliott E, Hietamies TM, et al.Diagnostic test accuracy of remote, multidomain cognitive assessment (telephone and video call) for dementia. The Coch database syst review 2022; 4(4): Cd013724.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8992929</ArticleId><ArticleId IdType="pubmed">35395108</ArticleId></ArticleIdList></Reference><Reference><Citation>Watt JA, Lane NE, Veroniki AA, et al.Diagnostic accuracy of virtual cognitive assessment and testing: systematic review and meta-analysis. J Amer Geria Soci 2021; 69(6): 1429&#x2013;1440.</Citation><ArticleIdList><ArticleId IdType="pubmed">33948937</ArticleId></ArticleIdList></Reference><Reference><Citation>Bauer RM, Iverson GL, Cernich AN, et al.Computerized neuropsychological assessment devices: joint position paper of the American academy of clinical neuropsychology and the national academy of neuropsychology. The Clin Neuropsy 2012; 26(2): 177&#x2013;196.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3847815</ArticleId><ArticleId IdType="pubmed">22394228</ArticleId></ArticleIdList></Reference><Reference><Citation>Leong V, Raheel K, Sim JY, et al.A new remote guided method for supervised web-based cognitive testing to ensure high-quality data: development and usability study. J Medi Inter Res 2022; 24(1): e28368.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778570</ArticleId><ArticleId IdType="pubmed">34989691</ArticleId></ArticleIdList></Reference><Reference><Citation>Weigel GRA, Sobel L, Salganicoff A, et al.Opportunities and barriers
for telemedicine in the U.S. During the COVID-19 emergency and beyond kaiser
family foundation, 2020. https://www.kff.org/womens-health-policy/issue-brief/opportunities-and-barriers-for-telemedicine-in-the-u-s-during-the-covid-19-emergency-and-beyond/</Citation></Reference><Reference><Citation>Tombaugh TN. Trail making test A and B: normative data stratified by age and education. Archi Clin Neuropsy 2004; 19(2): 203&#x2013;214.</Citation><ArticleIdList><ArticleId IdType="pubmed">15010086</ArticleId></ArticleIdList></Reference><Reference><Citation>Stroop JR. Studies of interference in serial verbal reactions. J exp psycho 1935; 18(6): 643&#x2013;662.</Citation></Reference><Reference><Citation>Corwin JBF, Bylsma FW. Psychological examination of traumatic encephalopathy. Clin Neuropsy 1993; 7(1): 3&#x2013;12. DOI: .</Citation></Reference><Reference><Citation>Wechsler D. Wechsler adult intelligence scale. New York: Psychological Corporation, 1955.</Citation></Reference><Reference><Citation>Smith A. Symbol digit modalities test. Los Angeles, CA: Western Psychological Services Los Angeles, 1973.</Citation></Reference><Reference><Citation>Stuss DT, Stethem LL, Poirier CA. Comparison of three tests of attention and rapid information processing across six age groups. Clini Neuropsycho 1987; 1(2): 139&#x2013;152. DOI: .</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>